These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29587478)

  • 1. Celecoxib Conjugated Fluorescent Probe for Identification and Discrimination of Cyclooxygenase-2 Enzyme in Cancer Cells.
    Gurram B; Zhang S; Li M; Li H; Xie Y; Cui H; Du J; Fan J; Wang J; Peng X
    Anal Chem; 2018 Apr; 90(8):5187-5193. PubMed ID: 29587478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Synthesis of a Novel NIR Celecoxib-Based Fluorescent Probe for Cyclooxygenase-2 Targeted Bioimaging in Tumor Cells.
    Wang X; Wang L; Xie L; Xie Z; Li L; Bui D; Yin T; Gao S; Hu M
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32899627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel near-infrared fluorescent probe for monitoring cyclooxygenase-2 in inflammation and tumor.
    Zhang Q; Han Z; Tao J; Zhang W; Li P; Tang L; Gu Y
    J Biophotonics; 2018 Jun; 11(6):e201700339. PubMed ID: 29341436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly sensitive naphthalene-based two-photon fluorescent probe for in situ real-time bioimaging of ultratrace cyclooxygenase-2 in living biosystems.
    Zhang H; Fan J; Wang K; Li J; Wang C; Nie Y; Jiang T; Mu H; Peng X; Jiang K
    Anal Chem; 2014 Sep; 86(18):9131-8. PubMed ID: 25144313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and structure-activity relationship studies of fluorescent inhibitors of cycloxygenase-2 as targeted optical imaging agents.
    Uddin MJ; Crews BC; Ghebreselasie K; Marnett LJ
    Bioconjug Chem; 2013 Apr; 24(4):712-23. PubMed ID: 23488616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid fluorescent conjugates of COX-2 inhibitors: search for a COX-2 isozyme imaging cancer biomarker.
    Bhardwaj A; Kaur J; Sharma SK; Huang Z; Wuest F; Knaus EE
    Bioorg Med Chem Lett; 2013 Jan; 23(1):163-8. PubMed ID: 23200247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorophore-labeled cyclooxygenase-2 inhibitors for the imaging of cyclooxygenase-2 overexpression in cancer: synthesis and biological studies.
    Bhardwaj A; Kaur J; Wuest F; Knaus EE
    ChemMedChem; 2014 Jan; 9(1):109-16, 240. PubMed ID: 24376205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocompatibility and intradiscal application of a thermoreversible celecoxib-loaded poly-N-isopropylacrylamide MgFe-layered double hydroxide hydrogel in a canine model.
    Willems N; Yang HY; Langelaan ML; Tellegen AR; Grinwis GC; Kranenburg HJ; Riemers FM; Plomp SG; Craenmehr EG; Dhert WJ; Papen-Botterhuis NE; Meij BP; Creemers LB; Tryfonidou MA
    Arthritis Res Ther; 2015 Aug; 17(1):214. PubMed ID: 26290179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells.
    Dandekar DS; Lopez M; Carey RI; Lokeshwar BL
    Int J Cancer; 2005 Jun; 115(3):484-92. PubMed ID: 15688368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Nile blue based infrared fluorescent probe: imaging tumors that over-express cyclooxygenase-2.
    Wang B; Fan J; Wang X; Zhu H; Wang J; Mu H; Peng X
    Chem Commun (Camb); 2015 Jan; 51(4):792-5. PubMed ID: 25424129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of Celecoxib on inflammation and synovial microcirculation in murine antigen-induced arthritis.
    Gebhard HH; Zysk SP; Schmitt-Sody M; Jansson V; Messmer K; Veihelmann A
    Clin Exp Rheumatol; 2005; 23(1):63-70. PubMed ID: 15789889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-Pot Synthesis of Coumarin-Indomethacin Hybrids as COX-2 Targeting Probes for Cancer Imaging.
    Wet-Osot S; Pewklang T; Chansaenpak K; Chudapongse N; Lai RY; Kamkaew A
    ChemMedChem; 2021 May; 16(10):1660-1666. PubMed ID: 33586347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-cancer effect of celecoxib and aerosolized docetaxel against human non-small cell lung cancer cell line, A549.
    Fulzele SV; Shaik MS; Chatterjee A; Singh M
    J Pharm Pharmacol; 2006 Mar; 58(3):327-36. PubMed ID: 16536899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-Step Transformation from Rofecoxib to a COX-2 NIR Probe for Human Cancer Tissue/Organoid Targeted Bioimaging.
    Xie L; Li R; Zheng B; Xie Z; Fang X; Dai T; Wang X; Li L; Wang L; Cuny GD; Eriksen J; Tu D; Chen Z; Wang X; Chen X; Hu M
    ACS Appl Bio Mater; 2021 Mar; 4(3):2723-2731. PubMed ID: 35014311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence discrimination of cancer from inflammation by molecular response to COX-2 enzymes.
    Zhang H; Fan J; Wang J; Dou B; Zhou F; Cao J; Qu J; Cao Z; Zhao W; Peng X
    J Am Chem Soc; 2013 Nov; 135(46):17469-75. PubMed ID: 24200121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
    FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near-Infrared Fluorescent Heptamethine Cyanine Dyes for COX-2 Targeted Photodynamic Cancer Therapy.
    Wangngae S; Siriwibool S; Chansaenpak K; Wet-Osot S; Lai RY; Kamkaew A
    ChemMedChem; 2022 May; 17(9):e202100780. PubMed ID: 35128814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agents.
    Uddin MJ; Crews BC; Blobaum AL; Kingsley PJ; Gorden DL; McIntyre JO; Matrisian LM; Subbaramaiah K; Dannenberg AJ; Piston DW; Marnett LJ
    Cancer Res; 2010 May; 70(9):3618-27. PubMed ID: 20430759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrimidine-based fluorescent COX-2 inhibitors: synthesis and biological evaluation.
    Tietz O; Kaur J; Bhardwaj A; Wuest FR
    Org Biomol Chem; 2016 Jul; 14(30):7250-7. PubMed ID: 27383140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting COX-1 by mofezolac-based fluorescent probes for ovarian cancer detection.
    Scilimati A; Ferorelli S; Iaselli MC; Miciaccia M; Pati ML; Fortuna CG; Aleem AM; Marnett LJ; Perrone MG
    Eur J Med Chem; 2019 Oct; 179():16-25. PubMed ID: 31229884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.